retatrutide clinical trial south korea ESC 2024: improves lipid and cardiovascular risk profile in Phase II Selling a premature fix for

When to seek medical advice: If you experience muscle pain, weakness, or dark urine whilst taking statins (potential signs of myopathy) If severe, persistent abdominal pain occurs whilst on GLP-1 therapy (potential pancreatitis) If cholesterol reduction is not achieved despite treatment adherence Before stopping or changing any prescribed medication If you develop new symptoms or side effects from any therapy Patients should discuss their individual cardiovascular risk profile and treatment options with their GP or specialist

Drucker, 2020)

A dedicated Phase 3 liver disease trial for retatrutide is currently underway

We're changing the way the world thinks about weight loss

How to Use Retatrutide Pens in the UK Safely: Step-by-Step Guide Using the correct injection technique helps ensure the medication is delivered accurately and consistently

However, the most significant changes in body weight generally occur after several months of consistent use